Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event; We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (no adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 043H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 09-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023).    No concomitant medication information was provided. The vial was initially thawed on 17May2023.  No treatment drug information was provided.   The case corresponds to 1st out of 30 patients who had received expired vaccine as reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-733163, US-MODERNATX, INC.-MOD-2023-733168, US-MODERNATX, INC.-MOD-2023-733173, US-MODERNATX, INC.-MOD-2023-733177, US-MODERNATX, INC.-MOD-2023-733182, US-MODERNATX, INC.-MOD-2023-733186, US-MODERNATX, INC.-MOD-2023-733188, US-MODERNATX, INC.-MOD-2023-733191, US-MODERNATX, INC.-MOD-2023-733194, US-MODERNATX, INC.-MOD-2023-733196, US-MODERNATX, INC.-MOD-2023-733198, US-MODERNATX, INC.-MOD-2023-733200, US-MODERNATX, INC.-MOD-2023-733199, US-MODERNATX, INC.-MOD-2023-733204, US-MODERNATX, INC.-MOD-2023-733206, US-MODERNATX, INC.-MOD-2023-733208, US-MODERNATX, INC.-MOD-2023-733211, US-MODERNATX, INC.-MOD-2023-733212, US-MODERNATX, INC.-MOD-2023-733335, US-MODERNATX, INC.-MOD-2023-733338, US-MODERNATX, INC.-MOD-2023-733343, US-MODERNATX, INC.-MOD-2023-733344, US-MODERNATX, INC.-MOD-2023-733346, US-MODERNATX, INC.-MOD-2023-733347, US-MODERNATX, INC.-MOD-2023-733349, US-MODERNATX, INC.-MOD-2023-733350, US-MODERNATX, INC.-MOD-2023-733351, US-MODERNATX, INC.-MOD-2023-733371, US-MODERNATX, INC.-MOD-2023-733373 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Follow-up received, updated vaccine administration date and I narrative.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-733188:Patient 8 US-MODERNATX, INC.-MOD-2023-733194:Patient 10 US-MODERNATX, INC.-MOD-2023-733199:Patient 13 US-MODERNATX, INC.-MOD-2023-733349:Patient 26 US-MODERNATX, INC.-MOD-2023-733350:Patient 27 US-MODERNATX, INC.-MOD-2023-733351:Patient 28 US-MODERNATX, INC.-MOD-2023-733346:Patient 24 US-MODERNATX, INC.-MOD-2023-733186:Patient 7 US-MODERNATX, INC.-MOD-2023-733198:Patient 12 US-MODERNATX, INC.-MOD-2023-733200:Patient 14 US-MODERNATX, INC.-MOD-2023-733204:Patient 15 US-MODERNATX, INC.-MOD-2023-733211:Patient 18 US-MODERNATX, INC.-MOD-2023-733335:Patient 20 US-MODERNATX, INC.-MOD-2023-733191:Patient 9 US-MODERNATX, INC.-MOD-2023-733173:Patient 4 US-MODERNATX, INC.-MOD-2023-733343:Patient 22 US-MODERNATX, INC.-MOD-2023-733212:Patient 19 US-MODERNATX, INC.-MOD-2023-733347:Patient 25 US-MODERNATX, INC.-MOD-2023-733344:Patient 23 US-MODERNATX, INC.-MOD-2023-733206:Patient 16 US-MODERNATX, INC.-MOD-2023-733208:Patient 17 US-MODERNATX, INC.-MOD-2023-733196:Patient 11 US-MODERNATX, INC.-MOD-2023-733182:Patient 6 US-MODERNATX, INC.-MOD-2023-733177:Patient 5 US-MODERNATX, INC.-MOD-2023-733163:Patient 2 US-MODERNATX, INC.-MOD-2023-733338:Patient 21 US-MODERNATX, INC.-MOD-2023-733168:Patient 3 US-MODERNATX, INC.-MOD-2023-733371:Patient 29 US-MODERNATX, INC.-MOD-2023-733373:Patient 30